The European Medicines Agency (EMA) have approved a new multi-dose preparation of Prevenar 13®, sponsored by biopharmaceutical company Pfizer, based on a study conducted by MRC Unit The Gambia. (more…)
The Quality Journey at MRCG started with the Clinical Trials Support Office (CTSO) in 2006 which lead to the establishment of the Quality Department in 2008. (more…)
The management team of MRC Unit The Gambia (MRCG) has introduced a pioneering employee health promotion programme for all staff. (more…)
- Detecting Foci of Malaria Transmission with School Surveys: A Pilot Study in the Gambia.
- The First Phylogeographic Population Structure and Analysis of Transmission Dynamics of M. africanum West African 1- Combining Molecular Data from Benin, Nigeria and Sierra Leone.
- Haematological and biochemical reference values of Gambian infants.